the hill country classic
Over many years and many millions of dollars, the Hill Country Classic has had the honor of supporting many worthy charities and making a difference in the lives of children. This year is no different.
Thanks to our generous Presenting Sponsor, the Accountable Alliance/USA Senior Care Network, the Hill Country Classic will continue its “Austin Vibe” for all who join in the event. Our colleagues in the insurance industry and key regulatory officials, as well as many of our friends and family, will be able to once again enjoy the experience that only the Hill Country Classic delivers – exceptional heart, incredible golf, and the casual fun and excitement that pairs with supporting a great cause.
APRIL 23-24, 2019
Join us for an exciting two day event that includes relevant insurance industry information and discussions, golf, games, and meals. Tuesday features our Regulatory Roundtable Lunch followed by a pairings dinner and silent auction in the evening. Wednesday will include breakfast, games, the Hill Country Classic Golf Tournament, and a closing ceremony and meal you won’t want to miss. We invite you to join us and be a part of the 2019 Hill Country Classic.
Riverplace Country Club
4207 River Place Blvd
Austin, TX 78730
Click the button below to be a part of the 2019 Hill Country Classic!
2019 Presenting Sponsor
Thank you to our 2019 Hill Country Classic Advisory Board!
Patricia Berry – UIR Media
Michael Bogle – USA Senior Care Network
David Brooks – Lifeshield National Insurance Company
Ana Bumgardner – EquiTrust Life Insurance Company
David Chambers – Cigna Supplemental Benefits
Alicia Hanson – Mutual of Omaha
Nathan Hightower – AmeriLife
Steve Knowles – Calsurance
Mark MacGillivray – Standard Insurance Company
Steve Miller – Association Member Benefits Advisors
Craig Miller – Ameritas
Greg Mitchell – Aureum RE
Jan Sipes – AmeriLife
Joe Weiser – Guaranty Income Life Insurance Company
Ty Wooldridge – Aetna
CYSTIC FIBROSIS FOUNDATION
WHAT WE DO
The mission of the Cystic Fibrosis Foundation is to cure cystic fibrosis and to provide all people with the disease the opportunity to live full, productive lives by funding research and drug development, promoting individualized treatment and ensuring access to high-quality, specialized care.